Search Results

BioMidwest

Aptar Named a CDP Supplier Engagement Leader for the Fourth Consecutive Year

AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, was named to the CDP Supplier Engagement Leaderboard, for the fourth consecutive year.

March 20, 2024

·

4 min read

Business

Aptar Declares Quarterly Dividend and Announces 2024 Annual Meeting Details

AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, declared a quarterly cash dividend of $0.41 per share.

January 18, 2024

·

2 min read

Business

Aptar Announces 2024 Quarterly Conference Call Dates

AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, announced the dates and times of quarterly conference calls for the year.

January 2, 2024

·

2 min read

BioMidwest

AptarGroup, Inc. Announces Pricing of $400 Million of 3.600% Senior Notes due 2032

AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced the pricing of an underwritten public offering of $400 million aggregate principal amount of its 3.600% Senior Notes due 2032.

March 2, 2022

·

3 min read

Policy

Aptar Awarded US FDA Contract to Study Opportunities for Low Global Warming Potential Propellants for Metered Dose Inhalers

AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, is announcing a contract with the U.S. Food and Drug Administration to study the challenges with developing low Global Warming Potential propellant metered dose inhalers.

December 4, 2023

·

4 min read

BioMidwest

Aptar Announces 2023 Investor Day

AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, will host an Investor Day on Friday, September 8, 2023.

August 24, 2023

·

1 min read

Business

Aptar Reports Second Quarter 2023 Results

AptarGroup, Inc. reported strong operational performance driven by continued growth of the company’s proprietary drug delivery systems and significant sequential improvement in injectables sales as Enterprise Resource Planning system implementation effects moderated.

July 27, 2023

·

23 min read

Business

Aptar Mourns Passing of Ervin J. LeCoque, First CEO and Board Chairman as a Publicly Traded Company

AptarGroup, Inc., announced with great sadness that Ervin “Erv” J. LeCoque, the first Chief Executive Officer and Chairman of the Board when Aptar became a publicly traded company, has passed away.

June 26, 2023

·

2 min read

Business

Aptar Declares Quarterly Dividend - April 20, 2023

AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active material science solutions and services, declared a quarterly cash dividend of $0.38 per share.

April 20, 2023

·

2 min read

Business

Aptar Reports First Quarter 2023 Results

AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active material science solutions and services, reported strong operational performance driven by Aptar’s Pharma and Beauty segments.

April 27, 2023

·

20 min read